{"id":"W3040840440","doi":"10.1056/nejmoa2003715","title":"Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS","year":2020,"lang":"de","type":"article","venue":"New England Journal of Medicine","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":543,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Hospital; Montreal Neurological Institute and Hospital","funders":"National Institute for Health and Care Research","keywords":"Medicine; Placebo; SOD1; Amyotrophic lateral sclerosis; Adverse effect; Randomization; Internal medicine; Confidence interval; Cerebrospinal fluid; Pharmacokinetics; Clinical endpoint; Hazard ratio; Anesthesia; Gastroenterology; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002679724,0.0004243424,0.002295956,0.0002958269,0.00008009589,0.00002142471,0.0004620988,0.0002384488,0.0009857486],"category_scores_gemma":[0.006193729,0.0002817328,0.000474056,0.0005083101,0.0004359235,0.0001740094,0.00008590662,0.001015066,0.00003429839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009966468,"about_ca_system_score_gemma":0.0009197916,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001089733,"about_ca_topic_score_gemma":0.000003598116,"domain_scores_codex":[0.9943314,0.0004117731,0.00241146,0.0003614293,0.001791433,0.0006925237],"domain_scores_gemma":[0.9940633,0.001277229,0.001431733,0.0003646271,0.0009474739,0.001915703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4341385,0.001211062,0.0002297904,0.0007844447,0.001849418,0.001214313,0.004258359,0.00003260405,0.1663915,0.0001095624,0.1826677,0.2071127],"study_design_scores_gemma":[0.6973958,0.05941355,0.0001447192,0.001801148,0.002031971,0.0001278383,0.000223282,0.0004798144,0.005259773,0.0001538152,0.2327741,0.0001941228],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8104,0.02025474,0.00210413,0.1598811,0.004595493,0.002068457,0.00009463013,0.00002195319,0.0005794606],"genre_scores_gemma":[0.9204155,0.01221219,0.001060981,0.002973418,0.06281225,0.000003499315,0.00002969109,0.00008363655,0.0004087874],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2632573,"threshold_uncertainty_score":0.9999635,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0854671521943647,"score_gpt":0.3706397178702581,"score_spread":0.2851725656758934,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}